MARKET

SPPI

SPPI

Spectrum Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.140
-0.080
-3.60%
After Hours: 2.160 +0.02 +0.93% 18:44 04/03 EDT
OPEN
2.180
PREV CLOSE
2.220
HIGH
2.220
LOW
2.100
VOLUME
987.47K
TURNOVER
--
52 WEEK HIGH
11.36
52 WEEK LOW
1.742
MARKET CAP
243.30M
P/E (TTM)
-1.7482
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SPPI stock price target is 9.25 with a high estimate of 14.00 and a low estimate of 4.000.

EPS

SPPI News

More
  • Spectrum Pharma (SPPI) Down 4.6% Since Last Earnings Report: Can It Rebound?
  • Zacks · 6d ago
  • Edited Transcript of SPPI earnings conference call or presentation 27-Feb-20 9:30pm GMT
  • Thomson Reuters StreetEvents · 03/19 04:05
  • The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment
  • Benzinga · 03/17 15:38
  • Spectrum Pharmaceuticals Cancelled Participation in Upcoming Medical Conference Due to Coronavirus Pandemic
  • Business Wire · 03/17 12:00

Industry

Biotechnology & Medical Research
-0.50%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About SPPI

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company operates through developing and commercializing oncology and hematology drug products segment. It focuses on developing ROLONTIS and POZIOTINIB. ROLONTIS is being investigated for the treatment of chemotherapy-induced neutropenia. POZIOTINIB is an oral pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR, HER) Family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations.
More

Webull offers kinds of Spectrum Pharmaceuticals, Inc. stock information, including NASDAQ:SPPI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPPI stock news, and many more online research tools to help you make informed decisions.